Matsumoto et al. [25] reported the inhibition of growth in liver and lung metastases in murine models of melanoma, lung cancer and lymphoma after G-CSF administration increased the number of circulating PMNs by just three fold. This evidence concerns the gene CSF3 and lung carcinoma.